TY - JOUR
KW - extended‐release injectable naltrexone
KW - opioid use disorder
KW - Drug Therapy
KW - Substance use disorder
KW - Opiates
KW - Naltrexone
KW - Substance use treatment
KW - article
KW - 3383:Drug & Alcohol Rehabilitation
AU - Colin Brewer
AU - Emmanuel Streel
A1 - 
AD - Stapleford Centre, London, United Kingdom brewerismo@gmail.com; Universite Libre de Bruxelles-Psychiatrie, Brussels, Belgium ; Brewer, Colin,brewerismo@gmail.com
BT - Addiction
C5 - Opioids & Substance Use
CP - 1
DO - 10.1111/add.14448
IS - 1
JF - Addiction
LA - English
M1 - Journal Article
PB - Wiley-Blackwell Publishing Ltd. Blackwell Publishing
PY - 2019
SN - 0965-2140, 0965-2140
SP - 188
EP - 189
EP - 
T1 - Long‐acting naltrexone has long‐acting benefits and 100% induction rates are not difficult to achieve
T2 - Addiction
TI - Long‐acting naltrexone has long‐acting benefits and 100% induction rates are not difficult to achieve
U1 - Opioids & Substance Use
U3 - 10.1111/add.14448
VL - 114
VO - 0965-2140, 0965-2140
Y1 - 2019
Y2 - 01
ER -